We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

41 hedge funds and large institutions have $28.5M invested in Abeona Therapeutics in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

687% more capital invested

Capital invested by funds: $3.62M → $28.5M (+$24.8M)

567% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 3

71% more funds holding

Funds holding: 24 → 41 (+17)

50% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 6

27.52% more ownership

Funds ownership: 20.06% → 47.58% (+28%)

Holders
41
Holders Change
+17
Holders Change %
+70.83%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
9
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.3M
2
AC
Armistice Capital
New York
+$4.14M
3
EC
EcoR1 Capital
California
+$4.07M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$3.78M
5
DM
Deerfield Management
New York
+$3.25M

Top Sellers

Rank Fund Capital Flow
1
KCM
Knoll Capital Management
Florida
-$269K
2
CT
Cambridge Trust
Massachusetts
-$243K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$58.5K
4
Renaissance Technologies
Renaissance Technologies
New York
-$20.6K
5
Group One Trading
Group One Trading
Illinois
-$11K
Name Holding Trade Value Shares
Change 		Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$4.19M +$1.02M +272,731 New
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$4.1M +$3.78M +1,010,870 +316%
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$3.54M +$4.3M +1,150,648 New
AC
4
Armistice Capital
New York
$3.41M +$4.14M +1,106,000 New
EC
5
EcoR1 Capital
California
$3.35M +$4.07M +1,086,956 New
DM
6
Deerfield Management
New York
$2.68M +$3.25M +869,565 New
ACM
7
AIGH Capital Management
Maryland
$2.01M +$1.91M +511,530 +364%
Vanguard Group
8
Vanguard Group
Pennsylvania
$901K +$314 +84 +0%
Barclays
9
Barclays
United Kingdom
$572K +$681K +181,978 +4,972%
Goldman Sachs
10
Goldman Sachs
New York
$523K +$635K +169,661 New
WVP
11
Worth Venture Partners
New Jersey
$494K +$470K +125,738 +362%
DMKJ
12
David M. Knott Jr
$462K +$561K +150,000 New
Millennium Management
13
Millennium Management
New York
$455K +$553K +147,779 New
ACM
14
Altium Capital Management
New York
$335K +$407K +108,696 New
ECM
15
ExodusPoint Capital Management
New York
$290K +$352K +94,171 New
Renaissance Technologies
16
Renaissance Technologies
New York
$193K -$20.6K -5,500 -8%
BlackRock
17
BlackRock
New York
$172K – – –
State Street
18
State Street
Massachusetts
$162K +$140K +37,400 +248%
XT
19
XTX Topco
Cayman Islands
$160K +$194K +51,888 New
Geode Capital Management
20
Geode Capital Management
Massachusetts
$122K +$14.7K +3,935 +11%
Jane Street
21
Jane Street
New York
$115K +$140K +37,401 New
Creative Planning
22
Creative Planning
Kansas
$61.6K +$74.8K +20,011 New
TRCT
23
Tower Research Capital (TRC)
New York
$52K +$61.3K +16,377 +5,335%
Deutsche Bank
24
Deutsche Bank
Germany
$49.3K – – –
PF
25
Phoenix Financial
Israel
$33.5K – – –
1
2

ABEO Hedge Fund Activity: Q4 2022 in Review

41 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q4 2022, worth a combined $28.5M — up 687% from $3.62M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new ABEO positions and 3 closed out — a net gain of 17 holders — while 9 added to existing stakes and 6 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $4.3M. The largest seller was Knoll Capital Management, exiting entirely with an estimated $269K sold.

  • 41 institutional investors held Abeona Therapeutics (ABEO) as of Q4 2022, up from 24 in Q3 2022.
  • Funds reported $28.5M of Abeona Therapeutics stock for Q4 2022, up 687% quarter-over-quarter.
  • 20 funds opened new Abeona Therapeutics positions in Q4 2022 and 3 closed out, a net change of +17 holders.
  • The largest Abeona Therapeutics buyer in Q4 2022 was Point72 Asset Management, an estimated $4.3M added.
  • The largest Abeona Therapeutics seller in Q4 2022 was Knoll Capital Management, an estimated $269K sold.

Based on aggregated 13F filings for Q4 2022.